Your fact-checks will appear here
The science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other possible drug-related problems.
No publicly available sources in the provided reporting name or describe “garaherb” specifically, so direct, product-level adverse-event counts for garaherb cannot be reported from these documents; in...
Human and veterinary drugs are regulated under broadly similar quality and GMP frameworks, but important practical and technical differences govern testing, approval dossiers, food‑safety requirements...
Regulators do more than rubber‑stamp sponsor analyses: they critically review, challenge, and sometimes re‑analyse datasets and models submitted for new drug approvals, and they continue to scrutinize...
There is no authoritative, product-specific safety dossier for Memoblast in the reporting provided, so definitive lists of its risks and side effects cannot be drawn from these sources; the only Memob...
Existing clinical evidence that ivermectin causes liver enzyme elevations in humans is limited but real: randomized/tolerability trials and pharmacovigilance databases document transient aminotransfer...
The materials provided do not contain independent clinical trials or standalone adverse-event reports for a product named "Karylief"; instead, reporting focuses on Karyopharm’s clinical programs for c...
Real‑world pharmacovigilance and observational studies consistently identify gastrointestinal events—nausea, vomiting, diarrhea, constipation and dyspepsia—as the most common adverse events (AEs) with...